Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Low molecular weight hyaluronic acid

Low Molecular Weight Sodium Hyaluronate (HA) · also known as Hyaluronic acid, Hyaluronan, Oral sodium hyaluronate, HA

Low molecular weight sodium hyaluronate holds water well and can help retain moisture in synovial fluid and skin. Some human studies used symptoms as the main outcome, and symptom improvement cannot prove the proposed mechanism of boosting the body’s own hyaluronic acid synthesis through CD44.

Typical dose: Low molecular weight, high-purity sodium hyaluronate 100–200 mg/day, swallowed with a meal or with warm water
Absorption and forms: Traditional ultra-high molecular weight hyaluronic acid (over 1000 kDa) is poorly absorbed by mouth. A rat pharmacokinetic study showed that oral absorption depends on molecular weight, and very little of either the 50 kDa or the 300 kDa preparation was absorbed. Radiolabeled tracer data alone also cannot show that intact molecules efficiently reach joints or skin.

Clinical uses and human evidence

Skin elasticity and hydration

BeneficialGrade B · Moderate evidence
Studies (2)
  1. Oe 2017 · Clin Cosmet Investig Dermatol · RCT · n=60 — Oral hyaluronan relieves wrinkles: a double-blinded, placebo-controlled study over a 12-week period
  2. Kawada 2015 · J Clin Biochem Nutr · RCT · n=61 — Ingestion of hyaluronans (molecular weights 800 k and 300 k) improves dry skin conditions: a randomized, double blind, controlled study

Osteoarthritis pain

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Wang 2021 · Medicine (Baltimore) · RCT · n=47 — The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial
  2. Tashiro 2012 · ScientificWorldJournal · RCT · n=60 — Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period

Mechanisms of action

Joint cartilage matrix glycan (GAGs/Aggrecan) repair and lubrication

★★★☆☆Mechanism evidence: grade CSecondary target

In rats, oral hyaluronic acid of different molecular weights raised hyaluronic acid-related markers in synovial fluid and lowered cartilage MMP expression. The idea that oral intake activates HAS-2 through CD44 and increases synovial fluid secretion in humans has not been directly confirmed, and symptom improvement in humans cannot prove this mechanism.

References (2)
  1. Wang 2025 · Rat and human studies: after oral hyaluronic acid of different molecular weights, rats showed higher synovial fluid hyaluronic acid-related markers and lower cartilage MMP expression; some human studies mainly measured symptoms.
  2. Sato 2020 · Rat pharmacokinetic study: absorption depended on molecular weight, and very little of the 50 kDa and 300 kDa preparations was absorbed.

Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair

★★★☆☆Mechanism evidence: grade CSecondary target

In mice given it orally, 35 kDa hyaluronic acid increased ZO-1 expression in the colonic epithelium and improved barrier function in an infection model. That molecular weight differs from the 50–200 kDa of this product, and extracellular water retention is not the same as stronger tight junctions. The related mechanism has not been confirmed in human keratinocytes.

References (1)
  1. Kim 2017 · Mouse oral study: 35 kDa hyaluronic acid increased ZO-1 expression in colonic epithelium and improved barrier function in an infection model.

Safety and drug interactions

Generally well tolerated; hyaluronic acid occurs naturally in the body. People with severe active tumors should not take very high doses long term on their own and should ask a doctor first. The claim that long-term oral use promotes tumor angiogenesis currently lacks direct clinical evidence.
Open in the interactive app ›